4
Changes in Ownership
Monte Rosa Therapeutics, Inc. Filed Acc 0001209191-24-000765
Options or other derivatives
- Principal Accounting Officer acquired 60,900 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Dunn Edmund Principal Accounting Officer | 2024-01-02 | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | D: show line 1 in the form | |||||
| Dunn Edmund Principal Accounting Officer | 2024-01-02 | Grant or award · Stock Option (Right to Buy) | +35,900 | 35,900 | D: show line 2 in the form |
Loading xslF345X05/doc4.xml…